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RESPONSIVENESS OF PHYSICAL FUNCTION
MEASURES:TREATMENT WITH CTLA4IG 
(BMS-188667) IN PATIENTS WITH ACTIVE
RHEUMATOID ARTHRITIS
Li T,Williams GR, L’Italien G, Kawabata H, Nuamah I
Bristol-Myers Squibb, Princeton, NJ, USA
OBJECTIVES: To examine the treatment effect of
CTLA4Ig on physical function and to evaluate the
responsiveness of different domains of physical function
compared to tender joint count, a highly sensitive efﬁcacy
measure for rheumatoid arthritis (RA). METHODS: In a
randomized, double blind, placebo-controlled trial, 339
subjects with active RA receiving methotrexate (MTX)
were randomized to 3 treatment arms (CTLA4Ig 2 or 10
mg/kg and placebo) given intravenously once monthly.
The Modiﬁed Health Assessment Questionnaire (mHAQ)
was used to assess physical function and was adminis-
tered monthly. It consisted of questions assessing eight
domains of physical function: dressing, arising, eating,
walking, hygiene, reach, grip, and common activities.
Mean change from baseline in the mHAQ scores were
compared between the CTLA4Ig and the placebo groups.
Relative efﬁciency of mHAQ domains were calculated as
(SESmHAQ / SEStender joint count)2, with SES denotes standard-
ized effect size. A relative efﬁciency >1 suggested that the
domain was more efﬁcient than the tender joint count in
detecting the observed treatment effect. RESULTS: At 
6 months, the mHAQ summary score improved 42% 
for the CTLA4Ig 10mg/kg group compared to 14% for
the placebo group. This improvement was considered to
be clinically meaningful based on the commonly accepted
threshold. Patients in the 10mg/kg group also experi-
enced statistically signiﬁcant improvements compared to
the placebo group in the following domains: eating (32%
more improvement), hygiene (32% more), grip (24%
more), dressing (20% more), and walking (16% more).
Moreover, these physical domains were shown to be as
responsive as the tender joint count to detect a treatment
effect, with relative efﬁciencies close to one. CONCLU-
SIONS: treatment with CTLA4Ig signiﬁcantly improved
physical function in patients with active RA, especially in
areas related to eating, hygiene, grip, and walking ability.
Measures in physical function are efﬁcient in detecting
clinical improvements important to patients.
QL3
DIABETIC PATIENTS’ WILLINGNESS TO PAY
FOR DIABETES EDUCATION BY PHARMACISTS:
VALIDITY OF CONTINGENT VALUATION
METHOD
Suh DC, Powers C, Russell LB2, Pogach LM3, Shin H,
Safford MM4
1Rutgers University, Piscataway, NJ, USA; 2Rutgers University,
New Brunswick, NJ, USA; 3VA Medical Center, East Orange,
NJ, USA; 4New Jersey Medical School, Newark, NJ, USA
OBJECTIVES: This study was conducted to measure dia-
betic patients’ willingness-to-pay (WTP) for diabetes edu-
cation provided by pharmacists utilizing the contingent
valuation method, to determine factors which inﬂuence
patients’ WTP, and to test starting point bias and scope
effects. METHODS: Diabetic patients, randomly selected
at 2 hospital endocrinology clinics, were interviewed 
to measure their WTP for education resulting in 3 
hypothetical risk-reductions in diabetic complications
(reduction from 75% without education to 37.5% with
education, 50%®25%, and 25%®12.5%) using a
bidding game with randomly assigned starting amounts
($10/$40). Sample mean (SM) and mean based on log-
normal distribution (LNM) were calculated. Mean WTP
was calculated using 2-part model (PM) with a smear 
estimator, and Heckman 2-stage model (HM) for sample
selection correction, which were further used to 
determine signiﬁcant factors inﬂuencing WTP amount.
RESULTS: A total of 283 patients were interviewed.
Patients’ mean age and household income was 53.5 years
and $60,202 respectively. In total, 59% of patients were
willing-to-pay. SMs were $36 ± $49 for 75%Æ37.5%;
$35 ± $50 for 50%Æ25%; and $26 ± $42 for
25%Æ12.5%. SMs were similar to LNMs. Means based
on HM were $41 ± $23 for the 75%Æ37.5%, $38 ± $19
for 50%Æ25%; and $27 ± $16 for 25%Æ12.5%, which
were nearly the same as means calculated based on PM.
In HM model, patients were willing-to-pay signiﬁcantly
larger amounts as risk-reduction level increased (P <
0.001), as starting amount increased (P < 0.001), and if
neuropathy was present (P < 0.001). Patients’ age, race,
hemoglobin A1c, type of diabetes, and history of retinopa-
thy were not signiﬁcant factors in predicting WTP
amount. CONCLUSIONS: Patients, on average, were
willing-to-pay between $26 and $41 for pharmacist 
provided diabetes education, depending on risk reduction
level (scope effect) and starting amounts (starting point
bias). The contingent valuation method is useful for 
determining the economic value of pharmacists’ educa-
tion. Further investigations are recommended to elucidate
factors inﬂuencing patients’ WTP for a variety of other
services.
QL4
SMOKING STATUS AND HEALTH-RELATED
QUALITY OF LIFE (HRQOL): FINDINGS FROM
THE BEHAVIORAL RISK FACTOR
SURVEILLANCE SYSTEM (BRFSS) DATA
Mody RR, Smith MJ
West Virginia University, Morgantown, WV, USA
OBJECTIVES: Smoking is one of the leading causes of
preventable mortality in the United States. The beneﬁts
of smoking cessation have been well documented, and
understanding the relationship between smoking and
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health-related quality of life (HRQOL) may be an impor-
tant factor in encouraging smokers to reduce or quit
smoking. This study examines the relationship between
smoking status and HRQOL using self-reported data
from the 2001 Behavioral Risk Factor Surveillance
System (BRFSS) for West Virginia. METHODS: Respon-
dents (N = 3093) were classiﬁed as current smokers, 
ex-smokers or non-smokers based on whether they had
smoked at least 100 cigarettes in their entire lifetime 
and whether they currently smoke. HRQOL data were
obtained from the health status section (4 items) of the
BRFSS survey. Logistic regression models adjusted for
demographics, obesity, and presence of comorbidities
(arthritis, asthma, cardiovascular disease and diabetes)
were conducted for the four HRQOL items. RESULTS:
Compared with current smokers, non-smokers had higher
odds of reporting good, very good or excellent general
health (OR = 1.80, 95% CI = 1.34 - 2.34) and lower
odds of reporting 14 or more days of poor physical health
during the previous 30 days (OR = 0.57, 95% CI = 0.43
- 0.76). The odds of reporting 14 or more days of poor
mental health during the previous 30 days were lower for
non-smokers (OR = 0.48, 95% CI = 0.36 - 0.63) and 
ex-smokers (OR = 0.68, 95% CI = 0.50 - 0.92) compared
to current smokers. Similarly, the odds of reporting 14 or
more days of activity limitations during the previous 30
days were lower for non-smokers (OR = 0.39, 95% CI =
0.27 - 0.55) and for ex-smokers (OR = 0.62, 95% CI =
0.43 - 0.89) compared to current smokers. In addition,
age, income and presence of comorbidities signiﬁcantly
explained variation in HRQOL. CONCLUSIONS: The
study results show a signiﬁcant relationship between
smoking status and self-reported HRQOL. Particularly,
ﬁndings that ex-smokers have reported fewer days of
poor mental health and activity limitations compared to
current smokers, may ﬁnd important implications in
designing smoking cessation programs.
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PD1
SUICIDE ATTEMPTS BY ADOLESCENTS:
HOSPITAL RESOURCE USE AND COSTS
O’Brien JA, Pitoniak-Morse CA, Caro J
Caro Research Institute, Concord, MA, USA
OBJECTIVE: Suicide by teenagers is an alarming
problem that is on the rise. This study examines admis-
sions resulting from a suicide attempt by an adolescent
and estimates the resulting cost of hospital care.
METHODS: Cases of adolescent, deﬁned as age 10
through 19 years, suicide attempts were identiﬁed using
ICD-9 diagnosis, and the corresponding E codes. Inpa-
tient hospital costs were developed based on 1999 dis-
charge data from four US states. Cost estimates include
all accommodation, ancillary and physician services.
National physician fee schedules were also used. Cost
estimates are reported in 2002 US$. Charges were
adjusted by means of a cost-to-charge ratio. RESULTS:
Of the 4067 suicide attempts identiﬁed, 70% were
female. The mean age for adolescents in this group was
16.5 years. A drug overdose was listed as the principal
diagnosis in 66% of cases. Almost three-quarters of cases
were admitted via the emergency room and 37% had a
stay in a special care unit. The mean length of stay was
3.4 days (range: 1–143) and the mean cost per stay was
$5,680 (range: $407–$385,132). The inpatient case fatal-
ity rate was less than 1%. Of those discharged alive, 26%
were transferred to either a mental health or residential
care facility, and 5.6% were readmitted within 12 months
due to another attempt. The majority (80%) of those
readmitted had one additional stay for another attempt
(range: 1–3) and all survived these subsequent attempts.
Managed care organizations were the largest single payer
group, responsible for half of the cases. CONCLUSIONS:
The overwhelming majority of cases treated in this setting
survive the attempt. Suicide attempts by adolescents 
generate substantial costs. Costs related to acute hospital
treatment of clinical conditions resulting from a suicide
attempt are but one economic aspect of managing these
patients, as many require post-discharge health care 
services.
PD2
A RANDOMIZED CONTROLLED TRIAL OF A
DRUG USE REVIEW INTERVENTION FOR
ANTIBIOTICS MEDICATIONS FOR OTITIS
MEDIA
Lee Y, Christensen DB
University of North Carolina at Chapel Hill, Chapel Hill, NC,
USA
OBJECTIVES: The objective of this study was to 
evaluate the effect of a 1-time, mailed intervention on
subsequent prescribing of antibiotics for initial episodes
of Acute Otitis Media (AOM). The intent was to alter
prescribing behavior in the direction of optimal treatment
guidelines. Past interventions mailed to prescribers have
had mixed results, and have rarely been assessed using
strong research designs. METHODS: A randomized con-
trolled trial was used. Physicians in the North Carolina
Medicaid Program with a lower prescribing rate of ﬁrst
line antibiotics for initial episodes of AOM than peers
during a prior 1-year period were randomized into inter-
vention (n = 413) and control (n = 375) groups. Cluster-
ing of prescribers by clinic and geographic area was done
to avoid contamination bias and statistical problems asso-
ciated with a lack of independence of observations. The
mailed intervention package contained a prescriber-
speciﬁc proﬁle detailing each physician’s prescribing 
rate compared to peers for initial episodes of AOM and 
prescription cost data, guidelines for the use of antibiotics
for AOM, a self assessment form with an opportunity 
to earn CME credits, and a prescriber response form. 
Prescribing was monitored for 21 months of baseline and
9 months of follow-up. RESULTS: On average across all
physicians in intervention group, prescribing of ﬁrst line
